Defeating
Brain Diseases
Starts With Earlier Insight

AgenT turns a standard blood draw into actionable biology to help detect neurodegenerative diseases earlier, stratify patients, and guide the development of better treatments.

Why Early Matters

Neurodegenerative diseases begin years before symptoms become visible. By the time memory, movement, or cognitive decline can be measured clinically, the underlying biology may already be advanced.

Changing their course requires earlier biological detection, better patient stratification, and intervention before irreversible decline.

Turning a Routine Blood Draw Into Biological Insights

AgenT combines blood-based multiomics, machine learning, and longitudinal clinical data to capture biological signals associated with neurodegenerative diseases.

By revealing disease biology before symptoms become irreversible, our platform supports earlier detection, patient stratification, and the development of better treatments.